It does seem like its on the border, though. When manufacturers, packers, distributors or their representatives promote prescription drugs to consumers and health care providers, the FDA says, it requires these communications to be truthful, balanced and not misleading
When measured in cost per percentage point of body weight lost, tirzepatide is actually more cost-efficient than semaglutide at brand-name prices, despite its similar or slightly higher list price because it produces greater weight loss per dollar spent
A January study from Chicago-based research company Circana found that GLP-1 users decreased the average number of items ordered per visit by just 1%, while favoring main dishes over sides
These medications have become game-changers for weight loss and diabetes management, especially for patients who have struggled with traditional methods
We cover the good, the bad, and the details most reviews conveniently skip